AUS
NZ
UK
CA
USA
IND
Health
Is This E-Commerce Powerhouse Approaching a Key Turning Point?
February 26, 2025 10:28 PM PST| By Team Kalkine MediaHighlights,Quarter results expected before the market opens on March 6,Earnings estimate is $0.90 per share with revenues reaching $332.70 billion,Stock opened recently at $42.53, reflecting upward momentum and strong liquidity measures,The e-commerc...
What Are the Key Insights from Akero Therapeutics' Latest Developments?
February 26, 2025 10:28 PM PST| By Team Kalkine MediaHighlights:,Akero Therapeutics (NASDAQ:AKRO) is set to release its latest earnings report, with an anticipated loss per share of ($0.98) for the quarter.,The stock has seen notable price fluctuations, trading between $17.86 and $58.40 over the past y...
Which Emerging Biopharma Firm Excels in Oncology and Brain Treatments?
February 26, 2025 10:22 PM PST| By Team Kalkine MediaHighlights,Distinctions in revenue and net earnings,Varying share figures and institutional support,Divergent therapy focuses: oncology versus brain health,Small-cap biopharmaceutical enterprises have drawn attention in the broader medical field by d...
Which Medical Device Companies Excel in Key Financial Metrics?
February 26, 2025 10:22 PM PST| By Team Kalkine MediaHighlights,Escalon Medical (OTC:ESMC) shows a higher earnings per share compared to Micron Solutions (NYSE:MICR).,Micron Solutions posts a larger overall revenue figure than Escalon Medical.,Both companies present lower volatility levels compared to...
Will Genetic Testing Technologies Spark the Next Healthcare Breakthrough?
February 26, 2025 10:22 PM PST| By Team Kalkine MediaHighlights,The company operates in specialized genetic offerings.,A negative net result contrasts with steady revenue figures.,Heightened volatility outpaces other organizations in its space.,Companies working on genetic testing have attracted widesp...
How Jazz Pharmaceuticals (NASDAQ:JAZZ) is Expanding its Global Footprint
February 26, 2025 10:00 AM PST| By Team Kalkine MediaHighlights,CIBC Asset Management and UMB Bank have boosted their stakes in Jazz Pharmaceuticals.,The company continues to grow its portfolio, addressing a range of medical needs.,Despite recent stock transactions, the company maintains favorable mark...
IQVIA Holdings (NYSE:IQV) A Look at Institutional Investments and Market Performance
February 26, 2025 09:55 AM PST| By Team Kalkine MediaHighlights,Major firms, including Sanctuary Advisors LLC and FMR LLC, have expanded their positions in IQVIA Holdings.,Recent earnings reports indicate a minor shortfall, yet the company maintains a strong market position.,Price targets have been adj...
How Has Arbutus Biopharma (NASDAQ:ABUS) Performed in the Market Recently
February 26, 2025 09:42 AM PST| By Team Kalkine MediaHighlights,Arbutus Biopharma has seen varying ratings from research firms, reflecting different market perspectives.,The company continues to maintain significant institutional interest, with firms adjusting their holdings.,Arbutus focuses on develop...
How Is Tempus AI (NASDAQ:TEM) Advancing Precision Medicine
February 26, 2025 09:30 AM PST| By Team Kalkine MediaHighlights,Tempus AI recorded higher trading volume following a price target adjustment by Needham & Company LLC.,Institutional ownership increased, now accounting for 24.22% of the company's total stock.,Tempus AI focuses on AI-powered precision me...
How Is SI-BONE (NASDAQ:SIBN) Expanding Its Presence in the Medical Device Sector
February 26, 2025 09:02 AM PST| By Team Kalkine MediaHighlights,SI-BONE reported earnings per share above expectations, contributing to increased market interest.,Institutional investors adjusted their holdings, reflecting engagement with the company.,The company continues to expand its presence in mus...
How Does Pyxis Oncology (NASDAQ:PYXS) Position Itself in Targeted Cancer Therapy
February 26, 2025 09:00 AM PST| By Team Kalkine MediaHighlights,Institutional investors have modified their holdings in Pyxis Oncology, reflecting active market engagement.,The company continues to advance its pipeline of cancer therapeutics, focusing on targeted treatments.,Stock performance has shown...
How Is Inari Medical Inc. (NASDAQ:NARI) Advancing Thrombectomy Treatments
February 26, 2025 08:56 AM PST| By Team Kalkine MediaHighlights,Institutional investors have adjusted their stakes in Inari Medical, contributing to market engagement.,The company maintains a structured financial approach, with stable revenue figures.,Inari Medical focuses on innovative medical solutio...
Merck & Co., Inc. (MRK): Key Asset in Bourgeon Capital's Portfolio
February 26, 2025 08:36 AM PST| By Team Kalkine MediaHighlights,Merck & Co., Inc.,(NYSE:MRK),is a leading player in the pharmaceutical sector, contributing significantly to Bourgeon Capital's portfolio.,The company is recognized for its extensive product line, including vaccines and oncology treatments...
How Elanco Animal Health (NYSE:ELAN) Responded to Market Pressure Following Q4 Results
February 26, 2025 08:34 AM PST| By Team Kalkine MediaHighlights,Elanco Animal Health reported a miss in earnings, with EPS falling short of expectations.,Analysts adjusted their price targets and ratings, showing mixed sentiment.,Institutional investors have continued to adjust their positions, with so...
Acadia Healthcare (NASDAQ: ACHC) The Influence of Institutional Investors on Its Stock
February 26, 2025 08:15 AM PST| By Team Kalkine MediaHighlights,Rhumbline Advisers raised its stake in Acadia Healthcare by 4.6%.,Notable institutional players like Wellington Management and JPMorgan Chase expanded their holdings.,Acadia Healthcare continues to provide crucial behavioral health service...
Why is Bruker Corporation (BRKR) Featured in The London Company SMID Cap Strategy?
February 26, 2025 08:01 AM PST| By Team Kalkine MediaHeadlines,Bruker Corporation,(NASDAQ:BRKR),specializes in scientific instruments and diagnostic solutions.,The stock experienced a one-month return of -9.12% and a year-over-year decrease of 39.08%.,Bruker Corporation closed at $50.99 per share on Fe...
What Is Driving Recent Moves in Agios Pharmaceuticals?
February 26, 2025 01:53 AM PST| By Team Kalkine MediaHighlights:,Institutional investment groups adjusted positions in recent quarters.,Key firms such as Venturi Wealth Management LLC and Mirae Asset Global Investments increased share quantities.,Financial metrics and trading ranges reflect an evolving...
Can This Biopharma Innovator Revolutionize Blood Disorder Treatment?
February 26, 2025 01:20 AM PST| By Team Kalkine MediaHighlights,Institutional investors reconfigured ownership.,Quarterly earnings per share exceeded expectations.,Peptide-based therapies advancing in clinical trials.,Protagonist Therapeutics (NASDAQ:PTGX) is a dynamic biopharmaceutical company operati...
Is Amarin Changing the Face of Cardiovascular Health?
February 26, 2025 12:29 AM PST| By Team Kalkine MediaHighlights,Amarin Corporation (NASDAQ:AMRN) opened at a modest price with a slight upward movement.,Institutional investors and hedge funds maintain active involvement in the firm.,The company emphasizes a global rollout of its flagship cardiovascula...
Analysts Assign Viking Therapeutics, Inc. (NASDAQ:VKTX) an Average Rating of "Buy"
February 25, 2025 11:28 PM PST| By Team Kalkine MediaHighlight,Viking Therapeutics has garnered significant attention from analysts, with a strong majority recommending a buy rating.,There has been notable insider activity, with key executives reducing their stake in the company.,Institutional investor...
